[go: up one dir, main page]

HK1106520A - Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor - Google Patents

Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor Download PDF

Info

Publication number
HK1106520A
HK1106520A HK07111925.0A HK07111925A HK1106520A HK 1106520 A HK1106520 A HK 1106520A HK 07111925 A HK07111925 A HK 07111925A HK 1106520 A HK1106520 A HK 1106520A
Authority
HK
Hong Kong
Prior art keywords
azabicycloheptyl
dopamine
receptor
respond
modulation
Prior art date
Application number
HK07111925.0A
Other languages
Chinese (zh)
Inventor
Karla Drescher
Andreas Haupt
Liliane Unger
Sean C. Turner
Wilfried Braje
Roland Grandel
Original Assignee
Abbott Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co. Kg filed Critical Abbott Gmbh & Co. Kg
Publication of HK1106520A publication Critical patent/HK1106520A/en

Links

HK07111925.0A 2004-10-14 2005-10-14 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor HK1106520A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/618,754 2004-10-14

Publications (1)

Publication Number Publication Date
HK1106520A true HK1106520A (en) 2008-03-14

Family

ID=

Similar Documents

Publication Publication Date Title
IL185016A0 (en) Compounds for the treatment of proliferative disorders
SI1833799T1 (en) 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT-2a SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
IL179508A0 (en) 2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders
IL190920A0 (en) Compounds for the treatment of metabolic disorders
EP1976377A4 (en) Compounds for the treatment of metabolic disorders
EP1976378A4 (en) Compounds for the treatment of metabolic disorders
ZA200703059B (en) 6-Amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
ZA200705008B (en) Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
IL201107A0 (en) Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
IL225745A0 (en) Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
EP1740530B8 (en) Substituted phenoxy- and phenylthio-derivatives for treating proliferative disorders
IL205468A0 (en) 1, 2, 4, - triazin - 3, 5 - dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor
EP1976510A4 (en) Compounds for the treatment of metabolic disorders
IL205469A0 (en) Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5 - ht6 receptor
HK1106520A (en) Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
HK1111596A (en) Triazole compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
HK1106221A (en) 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
HK1106219A (en) 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
HK1144811A (en) Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
HK1141018A (en) Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
HK1130771A (en) Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
EP1978948A4 (en) Compounds for the treatment of metabolic disorders
HK1121736A (en) Modulators of the h3 receptor useful for the treatment of disorders related thereto
HK1124486A (en) Compounds for the treatment of metabolic disorders
HK1124246A (en) Compounds for the treatment of metabolic disorders